Daiichi Sankyo Co., Ltd.TOKYO, Japan
Senior Researcher, R&D Division in Daiichi Sankyo Co., Ltd.
0896: Targeting Toll-Like Receptor 7 with DS-7011a, a Promising Novel Antagonistic Antibody for the Treatment of Systemic Lupus Erythematosus
Monday, November 13, 20239:00 AM – 11:00 AM PT
Disclosure information not submitted.